title: In vivo effects of urease-producing bacteria involved with the pathogenesis of infection-induced urolithiasis on renal urokinase and sialidase activity.
abstract: Many hypotheses have been proposed for renal stone formation. It has been argued that with infection-induced renal stones the hydrolysis of urea by bacterial urease increases urinary pH, with consequent stone formation. Unfortunately, this theory is not applicable to the micro-organisms that do not produce urease (e.g. Escherichia coli). It has been recently reported that E. coli reduces the urinary urokinase activity of male rats, but does not influence the urinary sialidase activity. This study has now been expanded to the urease-producing bacteria Proteus mirabilis, Staphylococcus aureus, S. epidermidis, Pseudomonas aeruginosa and Micrococcus luteus. Subcutaneous injections with these bacteria were found to significantly (P < 0.003) reduce the UK activity of extrarenally obstructed kidneys. The urease-producing mammalian skin bacterium, M. luteus, was, however, the exception (P = 0.1079). In contrast to S. epidermidis, P. aeruginosa and M. luteus (P < 0.0213), P. mirabilis and S. aureus had no effect on renal sialidase activity (P < 0.4047). These results may explain why Proteus species are predominant in infection-induced renal stones. According to the urokinase-sialidase hypothesis, a decrease in urinary urokinase activity should increase the uromucoid levels, whilst no effect on the urinary sialidase activity should favour conversion of urinary uromucoid to mineralizable matrix. These conditions may lead to renal stone formation. An increase in urinary pH resulting from urease-producing micro-organisms will increase salt precipitation on the uromucoid. It is thus concluded that urease-producing bacteria may play a double role in renal stone formation.
authors.affiliation: Department of Urology, HF Verwoerd Hospital, Pretoria, Republic of South Africa.
authors.forename: P J
authors.initials: PJ
authors.lastname: du Toit
authors.forename: C H
authors.initials: CH
authors.lastname: van Aswegen
authors.forename: J A
authors.initials: JA
authors.lastname: Nel
authors.forename: P L
authors.initials: PL
authors.lastname: Steyn
authors.forename: A J
authors.initials: AJ
authors.lastname: Ligthelm
authors.forename: D J
authors.initials: DJ
authors.lastname: du Plessis
mesh_terms: D000818:Animals; D001419:Bacteria / Q000201:enzymology*; D001424:Bacterial Infections / Q000150:complications; D007668:Kidney / Q000201:enzymology*; D008297:Male; D009439:Neuraminidase / Q000378:metabolism*; D011704:Pyelonephritis / Q000209:etiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014510:Urease / Q000096:biosynthesis*; D014545:Urinary Calculi / Q000209:etiology*; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism*
chemical_list: D009439:Neuraminidase; D014568:Urokinase-Type Plasminogen Activator; D014510:Urease